The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; BeiGene; Takeda
Research Funding - Acerta Pharma/AstraZeneca (Inst); Ayala Pharmaceuticals (I); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (I); De Novo Pharmaceuticals (Inst); Genentech/Roche (Inst); Ignyta (I); Incyte (Inst); Merck Sharp & Dohme (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); Seagen (Inst)
Outcomes of Burkitt lymphoma (BL) managed in academic (Acad) or community (Comm) centers: real-world evidence (RWE) from 30 US sites.
 
Adam J. Olszewski
Research Funding - Genentech/Roche (Inst); Spectrum Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
Izidore S. Lossos
Honoraria - Janssen Biotech
Consulting or Advisory Role - Janssen Scientific Affairs; Seagen; Verastem
Research Funding - NCI
Patents, Royalties, Other Intellectual Property - Stanford- Royalties
 
Andrzej Stadnik
No Relationships to Disclose
 
Stephen Douglas Smith
No Relationships to Disclose
 
Deepa Jagadeesh
Consulting or Advisory Role - Atara Biotherapeutics; Kyowa Hakko Kirin; Seagen; Verastem
Research Funding - Debiopharm Group (Inst); MEI Pharma (Inst); Regeneron (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst)
 
Seo-Hyun Kim
No Relationships to Disclose
 
Tycel Jovelle Phillips
Honoraria - Bayer; Genentech; Gilead Sciences; Incyte; Pharmacyclics; Seagen
Consulting or Advisory Role - Bayer; Curis; Genentech; Gilead Sciences; Gilead Sciences; Incyte; Pharmacyclics; Seagen
Research Funding - Abbvie; Bayer; Pharmacyclics/Janssen
 
Seema Naik
No Relationships to Disclose
 
Tatyana Feldman
Honoraria - Abbvie; Bayer; Bristol-Myers Squibb; Kite, a Gilead company; Pharmacyclics/Janssen; Seagen; Takeda
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Seagen
Speakers' Bureau - Abbvie; Celgene; Janssen; Kite, a Gilead company; Pharmacyclics; Seagen
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Cell Medica (Inst); Eisai (Inst); Kyowa Hakko Kirin (Inst); Kyowa Hakko Kirin (Inst); Pfizer (Inst); Portola Pharmaceuticals (Inst); Roche (Inst); Seagen (Inst); Trillium Therapeutics (Inst); Viracta Therapeutics (Inst); Viracta Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; Kite, a Gilead company; Pharmacyclics; Seagen; Takeda
 
Nishitha Reddy
No Relationships to Disclose
 
Suchitra Sundaram
No Relationships to Disclose
 
Seth Maliske
No Relationships to Disclose
 
Vaishalee Padgaonkar Kenkre
No Relationships to Disclose
 
Narendranath Epperla
Consulting or Advisory Role - Pharmacyclics
Speakers' Bureau - Verastem
 
Malvi Savani
No Relationships to Disclose
 
Craig Portell
No Relationships to Disclose
 
Neil Palmisiano
Research Funding - Abbvie/Genentech
 
Andreas Kirschmer Klein
No Relationships to Disclose
 
Andrew M. Evens
Honoraria - Affimed Therapeutics; Bayer; Cota Healthcare; Epizyme; Miltenyi Biotec; MorphoSys; Novartis; Pharmacyclics; Research to Practice; Seagen; Verastem; Verastem
Consulting or Advisory Role - Affimed Therapeutics; Bayer; Cota Healthcare; Epizyme; Miltenyi Biotec; MorphoSys; Novartis; Pharmacyclics; Seagen; Verastem
Research Funding - Tesaro
Travel, Accommodations, Expenses - Affimed Therapeutics; Bayer; Novartis; Pharmacyclics; Research to Practice; Seagen; Verastem